PGHL — Procter & Gamble Health Balance Sheet
0.000.00%
- IN₹83.25bn
- IN₹81.40bn
- IN₹14.08bn
Annual balance sheet for Procter & Gamble Health, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
R2022 June 30th | 2023 June 30th | 2024 June 30th | 2025 March 31st | 2026 March 31st | |
|---|---|---|---|---|---|
| Period Length: | — | 12 M | 12 M | 9 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IAS | IAS | IAS | IAS | IAS |
| Status: | Final | Final | Final | Final | Final |
| Cash | |||||
| Cash and Equivalents | |||||
| Short Term Investments | |||||
| Cash and Short Term Investments | 3,269 | 4,476 | 2,519 | 1,821 | 1,772 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 1,604 | 2,072 | 1,466 | 2,229 | 2,303 |
| Total Inventory | |||||
| Prepaid Expenses | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 6,080 | 7,961 | 5,242 | 5,264 | 5,563 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 1,496 | 1,733 | 1,315 | 1,220 | 1,128 |
| Net Intangible Assets | |||||
| Long Term Investments | |||||
| Long Term Notes Receivable | |||||
| Other Long Term Assets | |||||
| Total Assets | 8,881 | 11,012 | 7,944 | 7,942 | 8,414 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 2,319 | 3,039 | 2,189 | 2,153 | 2,549 |
| Capital Lease Obligations | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Total Other Liabilities | |||||
| Total Funded Status | |||||
| Total Liabilities | 2,716 | 3,503 | 2,561 | 2,572 | 3,168 |
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Total Equity | 6,165 | 7,509 | 5,382 | 5,370 | 5,246 |
| Total Liabilities & Shareholders' Equity | 8,881 | 11,012 | 7,944 | 7,942 | 8,414 |
| Total Common Shares Outstanding |